Workflow
Alico(ALCO)
icon
Search documents
Alico(ALCO) - 2021 Q1 - Earnings Call Transcript
2021-02-05 20:49
Alico, Inc. (NASDAQ:ALCO) Q1 2021 Results Conference Call February 4, 2021 8:30 AM ET Company Participants John Kiernan - President and CEO Rich Rallo - CFO Conference Call Participants Gerry Sweeney - ROTH Capital Operator Greetings, and welcome to Alico's First Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. As a reminder, today's conference is being recorded. On the call today are John Kiernan, President and Chief Executive Officer; and Rich Rallo, Chief Financ ...
Alico(ALCO) - 2020 Q4 - Earnings Call Transcript
2020-12-08 18:27
Alico, Inc. (NASDAQ:ALCO) Q4 2020 Earnings Conference Call December 8, 2020 8:30 AM ET Company Participants John Mills - ICR John Kiernan - President and CEO Rich Rallo - CFO Conference Call Participants Operator Welcome to Alico's Fourth Quarter and Full Year 2020 Earnings Conference Call. [Operator Instructions] As a reminder, today's conference is being recorded. I would like to now turn the call over to your host, Mr. John Mills with ICR. John Mills Thank you, Darryl. Good morning, and thank you for joi ...
Alico(ALCO) - 2020 Q4 - Annual Report
2020-12-08 13:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended September 30, 2020 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from ____________________to_________________________ Commission File Number: 0-261 ALICO, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction ...
Alico(ALCO) - 2020 Q3 - Quarterly Report
2020-08-06 12:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2020 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from____________________ to_________________________ Commission File Number: 0-261 Florida 59-0906081 (State or other jurisdiction of incorporation or organization) (I.R.S. Em ...
Alico(ALCO) - 2020 Q2 - Quarterly Report
2020-05-11 12:33
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Florida 59-0906081 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 10070 Daniels Interstate Court Suite 100 Fort Myers FL 33913 (Address of principal executive of ices) (Zip Code) Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock ALCO Nasdaq Global Select Market FORM 10-Q ☑ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exc ...
Alico(ALCO) - 2020 Q1 - Quarterly Report
2020-02-06 21:46
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Florida 59-0906081 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 10070 Daniels Interstate Court Suite 100 Fort Myers FL 33913 (Address of principal executive of ices) (Zip Code) Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock ALCO Nasdaq Global Select Market FORM 10-Q ☑ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exc ...
Alico(ALCO) - 2019 Q4 - Annual Report
2019-12-05 21:48
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Florida 59-0906081 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 10070 Daniels Interstate Court Suite 100 Fort Myers FL 33913 (Address of principal executive of ices) (Zip Code) Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock ALCO NASDAQ Global Select Market FORM 10-K ☑ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchan ...
Alico(ALCO) - 2019 Q3 - Quarterly Report
2019-08-06 20:45
Part I - FINANCIAL INFORMATION [Condensed Consolidated Financial Statements](index=4&type=section&id=Item%201.%20Condensed%20Consolidated%20Financial%20Statements) The company presents unaudited condensed consolidated financial statements, showing total assets decreased to **$399.5 million** and nine-month net income increased to **$21.2 million** Condensed Consolidated Balance Sheet Summary (in thousands) | Account | June 30, 2019 (Unaudited) | September 30, 2018 | | :--- | :--- | :--- | | **Total Current Assets** | $44,117 | $71,061 | | **Total Assets** | $399,519 | $423,422 | | **Total Current Liabilities** | $23,353 | $21,498 | | **Total Liabilities** | $216,236 | $245,827 | | **Total Stockholders' Equity** | $183,283 | $177,595 | Condensed Consolidated Statement of Operations Summary (in thousands) | Metric | Three Months Ended June 30, 2019 | Three Months Ended June 30, 2018 | Nine Months Ended June 30, 2019 | Nine Months Ended June 30, 2018 | | :--- | :--- | :--- | :--- | :--- | | **Total Operating Revenues** | $57,565 | $26,517 | $120,865 | $79,650 | | **Gross Profit** | $26,004 | $11,914 | $45,500 | $20,329 | | **Income from Operations** | $23,322 | $8,959 | $34,714 | $10,415 | | **Net Income** | $16,216 | $9,092 | $21,173 | $12,300 | | **Net Income Attributable to Alico** | $16,244 | $9,100 | $21,324 | $12,332 | Condensed Consolidated Statement of Cash Flows Summary (in thousands) | Cash Flow Activity | Nine Months Ended June 30, 2019 | Nine Months Ended June 30, 2018 | | :--- | :--- | :--- | | **Net cash provided by operating activities** | $41,686 | $16,119 | | **Net cash (used in) provided by investing activities** | $(14,348) | $19,163 | | **Net cash used in financing activities** | $(49,073) | $(12,124) | | **Net (decrease) increase in cash** | $(21,735) | $23,158 | [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=33&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses financial results, noting a **51.7% increase** in nine-month operating revenues to **$120.9 million** driven by citrus recovery and cost efficiency programs - The Alico 2.0 Modernization Program targets reducing citrus total expenses per acre to **$2,164** and cost per pound solid to **$1.56** by 2020[141](index=141&type=chunk)[142](index=142&type=chunk) - The company repurchased **752,234 shares** of common stock for **$25.6 million** through a tender offer completed on October 3, 2018[145](index=145&type=chunk) - Post-quarter, the company received **$5.8 million** from the Florida Citrus Recovery Block Grant related to Hurricane Irma, with potential for additional reimbursements[153](index=153&type=chunk)[129](index=129&type=chunk) Consolidated Results of Operations Summary (in thousands) | Metric | Nine Months Ended June 30, 2019 | Nine Months Ended June 30, 2018 | $ Change | % Change | | :--- | :--- | :--- | :--- | :--- | | **Total Operating Revenues** | $120,865 | $79,650 | $41,215 | 51.7% | | **Total Gross Profit** | $45,500 | $20,329 | $25,171 | 123.8% | | **Income from Operations** | $34,714 | $10,415 | $24,299 | 233.3% | | **Net Income Attributable to Alico** | $21,324 | $12,332 | $8,992 | 72.9% | [Quantitative and Qualitative Disclosures About Market Risk](index=46&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company reports no material changes to its market risk disclosures since the fiscal year ended September 30, 2018 - No material changes in quantitative and qualitative market risk disclosures have occurred since the fiscal year ended September 30, 2018 annual report[192](index=192&type=chunk) [Controls and Procedures](index=46&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded that disclosure controls and procedures were effective as of June 30, 2019, with no material changes to internal control over financial reporting - Disclosure controls and procedures were deemed effective by the Principal Executive Officer and Chief Financial Officer as of the reporting period end[194](index=194&type=chunk) - No material changes to internal control over financial reporting occurred during the third fiscal quarter[195](index=195&type=chunk) Part II - OTHER INFORMATION [Legal Proceedings](index=47&type=section&id=Item%201.%20Legal%20Proceedings) The company is not party to any current legal proceedings expected to materially adversely affect its financial condition, operations, or cash flows - The company reports no current legal proceedings expected to materially adversely affect its financial position, results of operations, or cash flows[197](index=197&type=chunk) [Risk Factors](index=47&type=section&id=Item%201A.%20Risk%20Factors) No material changes have occurred in the risk factors since the company's Annual Report on Form 10-K for the fiscal year ended September 30, 2018 - No material changes have occurred in the risk factors since the Annual Report on Form 10-K for the fiscal year ended September 30, 2018[198](index=198&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=47&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The company reports no sales of unregistered equity securities and no share repurchases under the 2017 authorization during the period - No sales of unregistered equity securities were made during the reporting period[199](index=199&type=chunk) - The company did not purchase any shares under its 2017 stock repurchase authorization during the three and nine months ended June 30, 2019[201](index=201&type=chunk) [Other Information](index=48&type=section&id=Item%205.%20Other%20Information) The Board amended Bylaws to make certain officer positions discretionary and adopted revised charters for key committees on August 5, 2019 - The company amended its Bylaws on August 5, 2019, making certain officer positions discretionary[203](index=203&type=chunk) - Revised charters for the Compensation, Executive, and Nominating & Governance Committees were adopted by the Board on August 5, 2019[206](index=206&type=chunk) [Exhibits](index=49&type=section&id=Item%206.%20Exhibits) This section lists exhibits filed with the Form 10-Q, including CEO/CFO certifications, amended bylaws, and committee charters - Filed exhibits include CEO and CFO certifications, amended Bylaws, and revised board committee charters[210](index=210&type=chunk)
Alico(ALCO) - 2019 Q2 - Quarterly Report
2019-05-07 20:46
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q þ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2019 or ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from____________________ to_________________________ Commission File Number: 0-261 Alico, Inc. (Exact name of registrant as specified in its charter) 59-0906081 Florida (Stat ...